Τετάρτη 28 Σεπτεμβρίου 2016

Sequential four-drug chemotherapy and intensity-modulated radiotherapy for larynx preservation in resectable advanced larynx and hypopharynx cancer: a pilot study

The value of additional use of cetuximab with the classical cisplatin, docetaxel and 5-fluorouracil regimen in larynx preservation remains unknown. This study was designed to resolve this issue and appraise its toxicity.

from #ORL via xlomafota13 on Inoreader http://ift.tt/2dm1nro
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου